NCI-Kenya awards research grants to institutions across Kenya with the goal of strengthening cancer research capacity in the country.
The funded projects are designed to produce high-quality, scalable, and impactful outcomes that inform public policy and contribute to reducing the burden of cancer.
High risk human papillomavirus (hrHPV) and cervical abnormalities in women attending selected health facilities.
Comprehensive cancer care integrating palliative care and survivorship initiatives for colorectal cancer patients.
Capacity Building for Molecular Detection of Gene Fusion in Pediatric Acute Lymphoblastic Leukemia cases
Benefit-sharing law and policy in cancer research in Kenya.
Oncology training needs assessment for health care professionals in selected counties in Kenya.
Automated breast cancer screening and detection leveraging modified-unet convolution neural network and capsule neural networks with X-ray images.
Enhancing Prevention of Gastrointestinal Malignancies through reducing aflatoxins in consumed foods. (Aflatoxin Free-Cancer Free).
Exploring risk factors for the increasing cases of lung cancer, studying selected areas in Kenya.
Burden of cancer: a community based cross-sectional study in Wajir county, Kenya.
Evaluating the effectiveness and implementation of the NHIF/SHIF benefit packages to provide financial risk protection for patients with cervical cancer.
Impact of access to affordable essential cancer medicines on financial status and quality of life of cancer patients.
A pilot study to determine the spectrum of opportunistic fungal and bacterial pathogens in cancer patients in selected cancer treatment facilities in Kenya.
Co-designing a culturally acceptable strategy to optimize uptake of HPV self-sample collection to increase cervical cancer screening and treatment for women in Kenya (SelHP).
Correlation of MRI pirads v 2.1 with histopathology and serum PSA findings in prostate cancer diagnosis in Kenya.
Optimizing cervical cancer screening in women of reproductive age among fisherfolk community through HPV DNA PCR testing.
This project focuses on understanding the genetic mutations specific to cancer patients in Kenya. By analyzing the genomic data of patients, we aim to develop targeted therapies that are more effective for the local population.
Objectives
Identify common genetic mutations in Kenyan cancer patients.
Develop personalized treatment plans based on genetic profiles.
Improve patient outcomes through targeted therapies.
LEARN MORE
HPV Vaccination Impact Study
This study assesses the long-term impact of HPV vaccination programs on cervical cancer rates in Kenya. We aim to provide data that supports the expansion of vaccination efforts and informs public health policies.
Objectives
Measure the reduction in cervical cancer incidence due to HPV vaccination.
Evaluate the cost-effectiveness of vaccination programs.
Recommend strategies to increase vaccination coverage.
LEARN MORE
Our Partners
View More
Partnerships
Partner With Us
By collaborating with the National Cancer Institute of Kenya, we can bring life-saving technology to those who need it most. Let's work together to build a healthier future for Kenyans.